Skip to main content
Premium Trial:

Request an Annual Quote

For-Profit, Nonprofit

Biotechnology executive Una Ryan believes everyone has the right to healthcare, says Technology Review's Emily Singer. As head of the nonprofit foundation Diagnostics for All, Ryan's goal is to provide access to healthcare and diagnostics in poor countries. To that end, her foundation is developing paper diagnostics — "cheap, portable, easy-to-manufacture tests that can be used in environments with few resources and little infrastructure," Singer says. Beyond a new kind of diagnostic, Ryan is also developing a new kind of business model. Although Diagnostics for All has received grants and charitable funding, Ryan is aware that these forms of funding are may not be adequate over the long term, Singer says. Hence, Diagnostics for All created its for-profit subsidiary, Paper Diagnostics, which will partner with companies to develop and market the tests for use in developed countries and reinvest its sales proceeds into the nonprofit, Singer adds.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.